Cargando…
Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
The 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs was dedicated to the management of rare pulmonary parenchymal and vascular diseases and rare variants of more common respiratory conditions https://bit.ly/3rq7b95
Autores principales: | Harari, Sergio, Adir, Yochai, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488847/ https://www.ncbi.nlm.nih.gov/pubmed/34937707 http://dx.doi.org/10.1183/16000617.0258-2021 |
Ejemplares similares
-
Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019) -
Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022) -
Pulmonary hypertension in patients with chronic myeloproliferative disorders
por: Adir, Yochai, et al.
Publicado: (2015) -
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
por: Adir, Yochai, et al.
Publicado: (2021) -
Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021)